🔎 Trials Near Me

Home › Chronic Lymphocytic Leukemia › Virginia › Richmond

Chronic Lymphocytic Leukemia clinical trials in Richmond, VA

6 studies for Chronic Lymphocytic Leukemia are looking for participants at sites in and around Richmond (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

RecruitingPhase 3
  • VCU Massey Comprehensive Cancer Center, Richmond
Ages 65 and older · All sexes · Updated Oct 2, 2026 · NCT07321652

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RecruitingObservational studyHealthy volunteers welcome
  • Bon Secours Richmond Community Hospital, Richmond
  • Bon Secours Saint Mary's Hospital, Richmond
  • Bon Secours Cancer Institute at Reynolds Crossing, Richmond
  • and 3 more
Ages 40 to 75 · All sexes · Updated Oct 2, 2026 · NCT05334069

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

RecruitingPhase 3
  • VCU Massey Cancer Center at Stony Point, Richmond
  • VCU Massey Comprehensive Cancer Center, Richmond
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT04269902

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

RecruitingPhase 1/2
  • Virginia Commonwealth University Massey Cancer Center, Richmond
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT05006716

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

RecruitingPhase 3
  • Virginia Commonwealth University (VCU) Medical Center ( Site 0030), Richmond
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06136559

A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

RecruitingPhase 3
  • Virginia Cancer Institute, Richmond
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT05254743

Chronic Lymphocytic Leukemia trials in other cities

Other studies in Richmond

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.